J1921 HCPCS code: Injection, labetalol hydrochloride (hikma), not therapeutically equivalent to j1920, 5 mg
J1921 is the HCPCS Level II code for injection, labetalol hydrochloride (hikma), not therapeutically equivalent to j1920, 5 mg. In 2024 Medicare paid an average of $1.18 per service for J1921 across 113 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. In 2024, about 8 clinicians billed Medicare for J1921 for 11 beneficiaries.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2023-07-01 |
| Last action effective | 2024-07-01 |
Who bills J1921 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 8 |
| Medicare beneficiaries | 11 |
| States with claims | 0 |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J1921, 2024–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2024 | 113 | 11 | $1.44 | $1.18 |
What changed for J1921
- 2023-07-01: J1921 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J1921?
J1921 is the HCPCS Level II code for injection, labetalol hydrochloride (hikma), not therapeutically equivalent to j1920, 5 mg. Short descriptor: "Inj labetalol hcl hikma, 5mg".
How much does Medicare pay for J1921?
In 2024, the average Medicare payment was $1.18 per service (average allowed $1.44).
Does Medicare cover J1921?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
Related J19 codes
- J1920 — Injection, labetalol hydrochloride, 5 mg
- J1930 — Injection, lanreotide, 1 mg
- J1931 — Injection, laronidase, 0.1 mg
- J1932 — Injection, lanreotide, (cipla), 1 mg
- J1938 — Injection, furosemide, 1 mg
- J1939 — Injection, bumetanide, 0.5 mg
- J1940 — Injection, furosemide, up to 20 mg
- J1941 — Injection, furosemide (furoscix), 20 mg
- J1942 — Injection, aripiprazole lauroxil, 1 mg
- J1943 — Injection, aripiprazole lauroxil, (aristada initio), 1 mg
- J1944 — Injection, aripiprazole lauroxil, (aristada), 1 mg
- J1945 — Injection, lepirudin, 50 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J1921
- Watch J1921 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J1921
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.